Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences. The drugmaker… [+4704 chars]Read More
Pfizers twicedaily weight loss pill joins a long list of obesity drug flops CNBC
